Intermedin ameliorates atherosclerosis in apoE null mice by modifying lipid profiles
- 10 August 2012
- journal article
- Published by Elsevier BV in Peptides
- Vol. 37 (2), 189-193
- https://doi.org/10.1016/j.peptides.2012.07.011
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Predictors of anterior and posterior wall carotid intima media thickness progression in men and women at moderate risk of coronary heart diseaseJournal of Clinical Lipidology, 2011
- Intermedin inhibits vascular calcification by increasing the level of matrix γ-carboxyglutamic acid proteinCardiovascular Research, 2009
- Role of adrenomedullin system in lipid metabolism and its signaling mechanism in cultured adipocytesAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Intermedin (adrenomedullin‐2): a novel counter‐regulatory peptide in the cardiovascular and renal systemsBritish Journal of Pharmacology, 2008
- Adrenomedullin 2 (AM2)/intermedin is a more potent activator of hypothalamic oxytocin-secreting neurons than AM possibly through an unidentified receptor in ratsPeptides, 2007
- Atherosclerosis: Disease Biology Affecting the Coronary VasculatureThe American Journal of Cardiology, 2006
- Proximal to Middle Left Coronary Artery Flow Velocity Ratio, As Assessed Using Color Doppler Echocardiography, Predicts Coronary Artery Atherosclerosis in MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2006
- Markers of Inflammation and Infection Influence the Outcome of Patients With Baseline Asymptomatic Carotid LesionsStroke, 2006
- Oxidized Low Density Lipoprotein: Atherogenic and Proinflammatory Characteristics during Macrophage Foam Cell Formation. An Inhibitory Role for Nutritional Antioxidants and Serum Paraoxonasecclm, 1999
- Atherosclerosis: Pathology, pathogenesis, and role of risk factorsDisease-a-Month, 1983